Research Paper Volume 15, Issue 24 pp 15134—15160
Experimental validation and pan-cancer analysis identified COL10A1 as a novel oncogene and potential therapeutic target in prostate cancer
Figure 13. COL10A1 highly expressed in prostate cancer cell lines and tissues. The Western Blot assay was performed the expression of COL10A1 with RWPE-1, LNCaP, DU-145, PC-3 and C4-2 cell lines (A). The Western Blot assay was performed the expression of COL10A1 with 4 pairs of prostate cancer specimens and adjacent tissues specimens (B). Immunohistochemistry analysis of COL10A1 protein expression in 10 pairs of the prostate cancer tissues and BPH tissues (C).